|
|
|
Targeting AMP-activated protein kinase in adipocytes to modulate obesity-related adipokine production associated with insulin resistance and breast cancer cell proliferation
Jean Grisouard, Kaethi Dembinski, Doris Mayer, Ulrich Keller, Beat Müller, Mirjam Christ-Crain Diabetology & Metabolic Syndrome 2011, 3:16 (20 July 2011)
Abstract | Full text | PDF
| PubMed
|
|
|
|
Cancer incidence in type 2 diabetes patients - first results from a feasibility study of the D2C cohort
Hans-Werner Hense, Hiltraud Kajüter, Jürgen Wellmann, Wolf U Batzler Diabetology & Metabolic Syndrome 2011, 3:15 (13 July 2011)
Abstract | Full text | PDF
| PubMed
|
|
|
|
Current european regulatory perspectives on insulin analogues
Harald G Enzmann, Martina Weise Diabetology & Metabolic Syndrome 2011, 3:14 (7 July 2011)
Abstract | Full text | PDF
| PubMed
|
|
|
|
Differences in bioactivity between human insulin and insulin analogues approved for therapeutic use- compilation of reports from the past 20 years
Haim Werner, Ernst A Chantelau Diabetology & Metabolic Syndrome 2011, 3:13 (29 June 2011)
Abstract | Full text | PDF
| PubMed |
|
|
|
|
Visceral adiposity, insulin resistance and cancer risk
Claire L Donohoe, Suzanne L Doyle, John V Reynolds Diabetology & Metabolic Syndrome 2011, 3:12 (22 June 2011)
Abstract | Full text | PDF
| PubMed
|
|
|
|
Albumin binding ligands and albumin conjugate uptake by cancer cells
Eva Frei Diabetology & Metabolic Syndrome 2011, 3:11 (15 June 2011)
Abstract | Full text | PDF
| PubMed
|
|
|
|
Mechanism of the mitogenic influence of hyperinsulinemia
Boris Draznin Diabetology & Metabolic Syndrome 2011, 3:10 (13 June 2011)
Abstract | Full text | PDF
| PubMed
|
|
|
|
Meeting Report: 3rd International Workshop on Insulin & Cancer Heidelberg, Germany, October 30-31, 2010
Ernst Chantelau, Doris Mayer Diabetology & Metabolic Syndrome 2010, 2:73 (21 December 2010)
Abstract | Full text | PDF
| PubMed
|